Zhejiang Medicine Co Ltd (600216):企業の財務・戦略的SWOT分析

◆英語タイトル:Zhejiang Medicine Co Ltd (600216) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12936
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Zhejiang Medicine Co Ltd (600216) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Zhejiang Medicine Co Ltd (Zhejiang Medicine) develops, manufactures and markets biological drugs, pharmaceutical intermediates and bio-pesticides. The company’s product portfolio consists of animal nutrition, active pharmaceutical ingredients (APls) and intermediates; antibiotics and human nutrition products including vitamin E, natural vitamin E, vitamin A, vitamin H, vitamin D3, coenzyme Q10, beta-carotene, fat-soluble vitamins, carotenoids and other pharmaceutical preparations. The company provides its products in large and small volume injections, freeze dried powder injections, tablets, hard and soft capsules, pills and oral solutions. It has two research and development (R&D) centers, namely, Shaoxing Research Institute of Pharmaceutical Industry and Shanghai Health Creation Biological Drug Research and Development Center. Zhejiang Medicine is headquartered in Shaoxing, Zhejiang, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Zhejiang Medicine Co Ltd – Key Facts 5
Zhejiang Medicine Co Ltd – Key Employees 6
Zhejiang Medicine Co Ltd – Key Employee Biographies 7
Zhejiang Medicine Co Ltd – Key Operational Employees 8
Zhejiang Medicine Co Ltd – Major Products and Services 9
Zhejiang Medicine Co Ltd – History 11
Zhejiang Medicine Co Ltd – Company Statement 13
Zhejiang Medicine Co Ltd – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Zhejiang Medicine Co Ltd – Business Description 16
R&D Overview 16
Zhejiang Medicine Co Ltd – Corporate Strategy 17
Zhejiang Medicine Co Ltd – SWOT Analysis 18
SWOT Analysis – Overview 18
Zhejiang Medicine Co Ltd – Strengths 18
Zhejiang Medicine Co Ltd – Weaknesses 19
Zhejiang Medicine Co Ltd – Opportunities 20
Zhejiang Medicine Co Ltd – Threats 21
Zhejiang Medicine Co Ltd – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Financial Performance 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 28
Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 29
Zhejiang Medicine Co Ltd, Recent Deals Summary 30
Section 5 – Appendix 31
Methodology 31
Ratio Definitions 31
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Zhejiang Medicine Co Ltd, Key Facts 5
Zhejiang Medicine Co Ltd, Key Employees 6
Zhejiang Medicine Co Ltd, Key Employee Biographies 7
Zhejiang Medicine Co Ltd, Key Operational Employees 8
Zhejiang Medicine Co Ltd, Major Products and Services 9
Zhejiang Medicine Co Ltd, History 11
Zhejiang Medicine Co Ltd, Subsidiaries 14
Zhejiang Medicine Co Ltd, Key Competitors 22
Zhejiang Medicine Co Ltd, Ratios based on current share price 23
Zhejiang Medicine Co Ltd, Annual Ratios 24
Zhejiang Medicine Co Ltd, Annual Ratios (Cont...1) 25
Zhejiang Medicine Co Ltd, Annual Ratios (Cont...2) 26
Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 28
Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 29
Zhejiang Medicine Co Ltd, Recent Deals Summary 30
Capital Market Ratios 31
Equity Ratios 32
Profitability Ratios 32
Cost Ratios 33
Liquidity Ratios 33
Leverage Ratios 33
Efficiency Ratios 34

List of Figures
Zhejiang Medicine Co Ltd, Ratio Charts 27
Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 28
Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 29

★海外企業調査レポート[Zhejiang Medicine Co Ltd (600216):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hareon Solar Technology Co Ltd (600401):電力:M&Aディール及び事業提携情報
    Summary Hareon Solar Technology Co Ltd (Hareon Solar) is a renewable energy company that manufactures and markets solar energy products. The company offers silicon cells and solar modules. Its products portfolio includes mono crystalline silicon solar cells, poly crystalline silicon solar cells, pol …
  • IQVIA Holdings Inc (IQV):企業の財務・戦略的SWOT分析
    IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dampier Gold Limited:企業の戦略・SWOT・財務分析
    Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report Summary Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Medigus Ltd (MDGS):企業の財務・戦略的SWOT分析
    Summary Medigus Ltd (Medigus) is a medical device company that develops, produces and markets endoscopic surgical devices for minimally invasive medical procedures. The company flagship product, Medigus ultrasonic surgical endostapler (MUSE) system, a comprehensive endoscopic device for the treatmen …
  • Merck & Co Inc (MRK)-医療機器分野:企業M&A・提携分析
    Summary Merck & Co Inc (Merck) focuses on the discovery, development, manufacture and commercialization of prescription pharmaceuticals, biologic therapies, vaccines and animal healthcare products. It offers prescription products for treating cardiovascular, cancer, immunology, infectious, respirato …
  • Coutts & Co.:企業の戦略・SWOT・財務情報
    Coutts & Co. - Strategy, SWOT and Corporate Finance Report Summary Coutts & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Haworth, Inc.
    Haworth, Inc. - Strategy, SWOT and Corporate Finance Report Summary Haworth, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Living Cell Technologies Ltd (LCT):企業の財務・戦略的SWOT分析
    Living Cell Technologies Ltd (LCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Micron Technology Inc:企業のM&A・事業提携・投資動向
    Micron Technology Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Micron Technology Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Eisai Co Ltd (4523):企業の財務・戦略的SWOT分析
    Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Acacia Research Corp:企業のM&A・事業提携・投資動向
    Acacia Research Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Acacia Research Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Ballard Power Systems Inc (BLDP):企業の財務・戦略的SWOT分析
    Ballard Power Systems Inc (BLDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Land Bank of Taiwan Co., Ltd:企業の戦略・SWOT・財務情報
    Land Bank of Taiwan Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Land Bank of Taiwan Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • System Dynamics International Incorporated:企業の戦略・SWOT・財務分析
    System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report Summary System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Team Health Holdings Inc-製薬・医療分野:企業M&A・提携分析
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care services. The organization’s practice areas include emergency medicine, anesthesiology, hospital medicine, hospital medicine subspecialties, ambulatory care, post-acute care and behavioral health serv …
  • Guess Inc (GES):企業の財務・戦略的SWOT分析
    Guess Inc (GES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • TOA Corporation:企業の戦略・SWOT・財務分析
    TOA Corporation - Strategy, SWOT and Corporate Finance Report Summary TOA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Humana Inc (HUM):企業の財務・戦略的SWOT分析
    Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • WPG Holdings Limited:企業の戦略・SWOT・財務情報
    WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Digna Biotech SL-製薬・医療分野:企業M&A・提携分析
    Summary Digna Biotech SL (Digna) is a biotechnology company that specializes in the development and commercialization of robust clinical therapeutic candidates. The company’s pipeline portfolio includes cutaneous manifestation of scleroderma, clinical indications for kidney transplant and liver surg …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆